Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction

Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction

Background Heart failure is a complex cardiovascular disease with a variety of etiologies and heterogeneity. The N-terminal pro-B-type natriuretic peptide (NT-proBNP) value has limited usefulness in diagnosing heart failure with preserved ejection fraction (HFpEF). Aim The aim of the present study...

Full description

Bibliographic Details
Main Authors:	Jyothirmayi Kanukurti, Noorjahan Mohammed, N. N. Sreedevi, Siraj Ahmed Khan, K.S.S. Sai Baba, M. Vijaya Bhaskar, O. Sai Satish, Shaik Mohammad Naushad, Iyyapu Krishna Mohan
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-08-01
Series:	Journal of Laboratory Physicians
Subjects:	sensitivity galectin-3 heart failure nt-probnp preserved ejection fraction
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1716608

Similar Items

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle
by: V V Kirillova, et al.
Published: (2018-09-01)

CLINICAL VALUE OF DETERMINING GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE
by: K. A. Gyamdzhyan, et al.
Published: (2017-12-01)

Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
by: Sha Fu, et al.
Published: (2021-06-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study
by: Giuseppe Armentaro, et al.
Published: (2021-08-01)

Evaluation of galectin-3 in patients with heart failure and its relationship with NT-proBNP levels: A case-control study
by: Namık Yiğit, et al.
Published: (2020-02-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
by: Radu Tanacli, et al.
Published: (2020-10-01)

Adaptive response triggered by the repeated SCUBA diving is reflected in cardiovascular, muscular, and immune biomarkers
by: Marko Žarak, et al.
Published: (2021-01-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction
by: Li Hao, et al.
Published: (2020-07-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

The Changes of Amino Terminal Pro B-type Natriuretic Peptide (NT-proBNP) Concentration and Left Ventricular Ejection Fraction on Doxorubicin Chemotherapy Patients
by: Telly Kamelia, et al.
Published: (2017-06-01)

Serum and Echocardiographic Markers May Synergistically Predict Adverse Cardiac Remodeling after ST-Segment Elevation Myocardial Infarction in Patients with Preserved Ejection Fraction
by: Tamara Pecherina, et al.
Published: (2020-05-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
by: E M Mezhonov, et al.
Published: (2012-09-01)

Serum Ürik Asit Düzeyinin Kardiyak Disfonksiyonda Prognostik bir Önemi Var mıdır?
by: Canan Topçuoğlu, et al.
Published: (2018-09-01)

Evaluation of NT-proBNP in children with heart failure younger than 3 years old
by: Iacob Daniela, et al.
Published: (2017-06-01)

N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with coronary heart diseas
by: S V Shalaev, et al.
Published: (2009-05-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Relationship between N-terminal pro-B-type natriuretic peptide and renal function: the effects on predicting early outcome after off-pump coronary artery bypass surgery
by: Youn Yi Jo, et al.
Published: (2011-07-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD
by: Li H, et al.
Published: (2020-01-01)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
by: Ewa Romuk, et al.
Published: (2020-01-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

Utility of N-terminal pro-brain natriuretic peptide in detecting diastolic dysfunction in asymptomatic hypertensive patients: comparison with echocardiography
by: Sahadeb Prasad Dhungana, et al.
Published: (2019-03-01)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
by: Clotilde Roy, et al.
Published: (2020-10-01)

CIRCULATING CARDIAC BIOMARKERS IN HEART FAILURE: A CRITICAL LINK TO BIOMARKER-GUIDED THERAPY
by: Alexander E. Berezin
Published: (2019-10-01)

N-terminal natriuretic propeptide type-b (NT-proBNP) and left ventricular ejection fraction in acute phase of st-segment elevation myocardial infarction and 1-year later
by: Jernej Markež, et al.
Published: (2007-11-01)

Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
by: Wei Pan, et al.
Published: (2020-04-01)

Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register
by: Björn Eriksson, et al.
Published: (2019-11-01)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
by: Carolin Gehlken, et al.
Published: (2021-08-01)

Propéptido natriurético tipo B N-terminal en adultos mayores ecuatorianos
by: Rubí Eliana Bermello Zamora, et al.
Published: (2020-01-01)

Evaluation of in-Hospital NT-ProBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy
by: Gholamreza Davoodi, et al.
Published: (2014-01-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)